Stockscreener 앱 받기
141.68
0.12%
0.17
시장 영업 전:
141.68
Illumina Inc 주식(ILMN)의 최신 뉴스
Illumina stock (US4523271090): new responsibility report highlights growth drivers in genomics - AD HOC NEWS
Illumina now sequences over 10 human genomes a minute, trims packaging 87% - Stock Titan
SomaLogic Inc stock (US82489T1043): Illumina takeover reshapes proteomics story - AD HOC NEWS
Illumina stock (US4523271090): analysts see limited upside after volatile Nasdaq recovery - AD HOC NEWS
Illumina price tries to vent off overbought saturationForecast today18-05-2026 - Economies.com
NXP, Illumina, StoneX Group: Momentum Stocks Analysis (Buy & Sell)May 2026News and Statistics - IndexBox
Illumina stock (US4523271090): analysts see limited upside after recent volatility - AD HOC NEWS
Illumina stock (US4523271090): analysts see limited upside after volatile trading - AD HOC NEWS
Illumina Inc stock (US4523271090): spin-off progress and earnings keep investors alert - AD HOC NEWS
Illumina, Inc. Trade Ideas — EUROTLX:4ILMN - TradingView
SomaLogic Inc stock (US82489T1043): Illumina merger closes and reshapes proteomics story - AD HOC NEWS
Illumina Inc stock (US4523271090): gene sequencing player in focus after latest earnings and divesti - AD HOC NEWS
Illumina CEO Joins Trump-Xi Summit: Here’s What It Means for ILMN Stock - TIKR.com
Illumina, Inc.Common Stock (Nasdaq:ILMN) Stock Quote - FinancialContent
Illumina's Mid-Teens Clinical Growth Appears Sustainable Over Next 1 to 2 Years, RBC Says - Moomoo
Swiss Life Asset Management Ltd Sells 47,498 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina Insider Sold Shares Worth $47,931,975, According to a Recent SEC Filing - marketscreener.com
Illumina stock (US4523271090): gene sequencing player in focus after leadership and strategy updates - AD HOC NEWS
Is Illumina (ILMN) Pricing Look Interesting After 77% One Year Share Price Gain - Yahoo Finance
Illumina director Keith Meister sells $47.9m in shares - Investing.com India
Illumina director Keith Meister sells $47.9m in shares By Investing.com - Investing.com South Africa
Illumina(ILMN.US) Director Sells US$47.93 Million in Common Stock - Moomoo
Corvex Funds tied to Illumina (NASDAQ: ILMN) sell shares and partly unwind equity swaps - Stock Titan
RBC Capital assumes Illumina stock coverage with outperform rating - Investing.com
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
[SCHEDULE 13G/A] ILLUMINA, INC. Amended Passive Investment Disclosure - Stock Titan
Illumina stock (US4523271090): Shares up 10.6% YTD amid strong earnings beat - AD HOC NEWS
Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight - GlobeNewswire Inc.
Bioinformatics Market Trends, Investment Opportunities, and Growth Analysis Through 2033 | Affymetrix Inc, - EIN News
Here Are Thursday’s Top Wall Street Analyst Research Calls: Commercial Metals, Doximity, Draftkings, Hut 8, Illumina, Lowe’s, TeraWulf, Starbucks, Whirlpool, Wix.com, and More - Yahoo Finance
Daiwa Securities Upgrades Illumina to Outperform From Neutral, Adjusts Price Target to $155 From $128 - marketscreener.com
Bioinformatics Platforms Market Is Going to Boom | • Illumina Inc • Thermo Fisher Scientific Inc • QIAGEN N.V - openPR.com
ILMN Stock Analysis 2026: Should You Invest in Illumina Now? - sebd.in
Number of shareholders of Illumina, Inc. – SIX:ILMN - TradingView
Illumina (ILMN) Form 144 lists 600,000 shares with Goldman Sachs broker - Stock Titan
Illumina stock (US4523271090): Q1 2026 earnings beat signals recovery momentum - AD HOC NEWS
Illumina stock (US4523271090): Consensus Hold rating reflects steady biotech positioning - AD HOC NEWS
The Bull Case For Illumina (ILMN) Could Change Following Upgraded 2026 Outlook And Major BuybackLearn Why - Sahm
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina stock (US4523271090): Analyst consensus shifts to Hold amid mixed signals - AD HOC NEWS
Illumina Inc. stock (US4523271090): Latest developments and business overview - AD HOC NEWS
SomaLogic stock (US82489T1043): Completed $350M sale to Illumina - AD HOC NEWS
Illumina Innovation Fund Iii, L.p. Net Worth (2026) - GuruFocus
How Illumina employees work to move healthcare toward precision medicine - Illumina
Corvex funds (NASDAQ: ILMN) exercise Illumina equity swaps, retain large position - Stock Titan
The future of global food security may depend on quality agrigenomics software - Illumina
NovaSeq X software update v1.4 improves data quality and customer usability - Illumina
Illumina stock (US4523271090): Q1 earnings beat lifts shares 8% YTD - AD HOC NEWS
We Think That There Are Issues Underlying Illumina's (NASDAQ:ILMN) Earnings - simplywall.st
Illumina, Inc. (ILMN) Stock Analysis: Navigating the Genomic Frontier with Strong Revenue Growth and Strategic Partnerships - DirectorsTalk Interviews
Avoiding Lag: Real-Time Signals in (ILMN) Movement - Stock Traders Daily
Mitsubishi UFJ Asset Management Co. Ltd. Raises Position in Illumina, Inc. $ILMN - MarketBeat
HPE, Charles Schwab, Zomedica, Illumina, Circle Insider Shake-Up - TipRanks
Illumina Inc. stock (US4523271090): Earnings beat and momentum lift shares - AD HOC NEWS
Uber, Exxon Mobil, Illumina, Diamondback Energy: CNBC's 'Final Trades' - MSN
Dna Forensic Market Is Booming So Rapidly | Agilent Technologies, Illumina, Bio-Rad Laboratories - openPR.com
Illumina Inc. Stock (US4523271090): Analyst Ratings and Price Targets in Focus - AD HOC NEWS
Illumina SVP Jakob Wedel Christensen sells $97,328 in stock - Investing.com UK
Illumina SVP Jakob Wedel Christensen sells $97,328 in stock By Investing.com - Investing.com Australia
Illumina (NASDAQ: ILMN) SVP logs 700-share sale and 233-share tax withholding - Stock Titan
Illumina Patent Lawsuit Targets BillionToOne Prenatal Tests (1) - Bloomberg Law News
Illumina showcases multi-omics potential to advance precision medicine in India - Indian Pharma Post
2.24%
0.29%
자본화:
|
볼륨(24시간):